Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOBQ | Common Stock | Award | $97.5K | +150K | +50.25% | $0.65 | 449K | Oct 6, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MOBQ | Common Stock | Award | $300K | 525K | Oct 6, 2023 | Common Stock | 429K | $0.70 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | The 448,535 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. |
F2 | The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust. Salkind has the right to convert $300,000 loan into common stock at $.70 per share or into the terms of a financing completed before November 30, 2023. |
F3 | Not applicable. |